14.39 0.1 (0.7%) | 12-06 16:00 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 17.43 ![]() |
1-year : | 20.36 ![]() |
Resists | First : | 14.93 ![]() |
Second : | 17.43 ![]() |
Pivot price | 13.95 ![]() |
|||
Supports | First : | 12.56 ![]() |
Second : | 11.1 ![]() |
MAs | MA(5) : | 14.29 ![]() |
MA(20) : | 13.76 ![]() |
MA(100) : | 13.24 ![]() |
MA(250) : | 14.66 ![]() |
|
MACD | MACD : | 0.4 ![]() |
Signal : | 0.4 ![]() |
%K %D | K(14,3) : | 78.1 ![]() |
D(3) : | 81.1 ![]() |
RSI | RSI(14): 61.1 ![]() |
|||
52-week | High : | 19.09 | Low : | 9.93 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HLVX ] has closed below upper band by 18.3%. Bollinger Bands are 48.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 14.95 - 15.01 | 15.01 - 15.06 |
Low: | 14.09 - 14.17 | 14.17 - 14.23 |
Close: | 14.27 - 14.38 | 14.38 - 14.48 |
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Tue, 05 Dec 2023
Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 20,000 Shares of HilleVax Inc ... - Yahoo Finance
Thu, 30 Nov 2023
Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to Trade - Yahoo Finance
Fri, 24 Nov 2023
Have Insiders Sold HilleVax Shares Recently? - Simply Wall St
Wed, 22 Nov 2023
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by American International Group Inc. - Defense World
Tue, 21 Nov 2023
Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 10,000 Shares of HilleVax Inc ... - Yahoo Finance
Tue, 26 Sep 2023
HilleVax, Inc.'s (NASDAQ:HLVX) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures - Simply Wall St
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Biotechnology
|
|
Shares Out | 48 (M) |
Shares Float | 20 (M) |
Held by Insiders | 8.9 (%) |
Held by Institutions | 72.6 (%) |
Shares Short | 495 (K) |
Shares Short P.Month | 535 (K) |
EPS | -2.29 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 6.55 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -21.1 % |
Return on Equity (ttm) | -36.8 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -2.39 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -84 (M) |
Levered Free Cash Flow | -68 (M) |
PE Ratio | -6.29 |
PEG Ratio | 0 |
Price to Book value | 2.19 |
Price to Sales | 0 |
Price to Cash Flow | -8.33 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |